GL Pharm Tech Corp. (KOSDAQ:204840)

South Korea flag South Korea · Delayed Price · Currency is KRW
970.00
-10.00 (-1.02%)
Last updated: Mar 25, 2025
-26.24%
Market Cap 78.89B
Revenue (ttm) 26.05B
Net Income (ttm) -2.34B
Shares Out 76.97M
EPS (ttm) -31.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 121,482
Average Volume 118,377
Open 980.00
Previous Close 980.00
Day's Range 920.00 - 982.00
52-Week Range 900.00 - 1,400.00
Beta 1.04
RSI 74.78
Earnings Date Mar 14, 2025

About GL Pharm Tech

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 27
Stock Exchange KOSDAQ
Ticker Symbol 204840
Full Company Profile

Financial Performance

In 2024, GL Pharm Tech's revenue was 26.05 billion, an increase of 0.06% compared to the previous year's 26.03 billion. Losses were -2.34 billion, -37.64% less than in 2023.

Financial Statements

News

There is no news available yet.